| 1 |
Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]．CA Cancer J Clin，2018，68(6):394-424.
|
| 2 |
Tashiro H, Aikata H, Waki K，et al.Treatment strategy for early hepatocellular carcinomas：comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection[J]．J Surg Oncol，2011，104(1):3-9.
|
| 3 |
Izzo F, Granata V, Grassi R, et al.Radiofrequency Ablation and Microwave Ablation in Liver Tumors：An Update[J]．Oncologist，2019，24(10):e990-e1005.
|
| 4 |
Jin S, Tan S, Peng W, et al.Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma：a systematic review and meta-analysis[J]．World J Surg Oncol，2020，18(1):199.
|
| 5 |
Ganne-Carrié N, Nault JC, Ziol M, et al.Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma[J]．Hepat Oncol，2014，1(4):395-408.
|
| 6 |
Harrison LE, Koneru B, Baramipour P, et al.Locoregional recur-rences are frequent after radiofrequency ablation for hepatocellular carcinoma[J]．J Am Coll Surg，2003，197(5):759-764.
|
| 7 |
Cohen GS, Black M．Multidisciplinary management of hepatocellular carcinoma：a model for therapy[J]．J Multidiscip Healthc，2013，6:189-95.
|
| 8 |
Wang F, Numata K, Nihonmatsu H, et al.Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation[J]．IntJ Hyperthermia，2020，37(1):1149-1158.
|
| 9 |
Li Q, Chen K, Huang W, et al.Minimally invasive photothermal ablation assisted by laparoscopy as an effective preoperative neoadjuvant treatment for orthotopic hepatocellular carcinoma[J]．Cancer Lett，2021，496:169-178.
|
| 10 |
Schullian P, Laimer G, Putzer D, et al.Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection[J]．Eur J Surg Oncol，2020，46(8):1503-1509.
|
| 11 |
Solbiati L, Ierace T, Gennaro N, et al.Percutaneous radiofrequency ablation of HCC：reduced ablation duration and increased ablation size using single，internally cooled electrodes with an optimized pulsing algorithm[J]．Int J Hyperthermia，2020，37(1):861-867.
|
| 12 |
Han TS, Ban HS, Hur K, et al.The Epigenetic Regulation of HCC Metastasis[J]．Int J Mol Sci，2018，19(12):3978.
|
| 13 |
Lassandro G, Picchi SG, Bianco A，et al.Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC：a five years study[J]．Med Oncol，2020，37(4):25.
|
| 14 |
Cui Y, Wu X, Lin C，et al.AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway[J]．Oncogene，2019，38(27):5516-5529.
|
| 15 |
Dong P, Wang X, Liu L，et al.Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma[J]．J Hepatol，2020，28:S0168-8278(20)30400-1.
|
| 16 |
Zhao M, Wang Y, Liu Y，et al.C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway[J]．Cancer Biol Ther，2019，20(12):1430-1442.
|
| 17 |
Greten TF, Manns MP, Korangy F．Immunotherapy of hepatocellular carcinoma[J]．J Hepatol，2006，45(6):868-878.
|
| 18 |
Rochigneux P, Nault JC, Mallet F, et al.Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma[J]．Oncoimmunology，2019，8(8):1615818.
|
| 19 |
Wu H, Li SS, Zhou M，et al.Palliative Radiofrequency Ablation Accelerates the Residual Tumor Progression Through Increasing Tumor-Infiltrating MDSCs and Reducing T-Cell-Mediated Anti-Tumor Immune Responses in Animal Model[J]．Front Oncol，2020，10:1308.
|
| 20 |
Bian H, Zheng JS, Nan G，et al.Randomized trial of [131I]metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation[J]．J Natl Cancer Inst，2014，106(9):dju239.
|
| 21 |
Duffy AG, Ulahannan SV, Makorova-Rusher O，et al.Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma[J]．J Hepatol，2017，66(3):545-551.
|
| 22 |
吴沛宏，陈奇峰，李旺．肝细胞癌微创与多学科综合诊疗——2018广州共识[J]．临床肝胆病杂志，2019，35(10):2176-2184.
|
| 23 |
Li H, Meng X, Zhang D, et al.Ginkgolic acid suppresses the invasion of HepG2 cells via downregulation of HGF/c-Met signaling[J]．Oncol Rep，2019，41(1):369-376.
|
| 24 |
Shao J, Shi CJ, Li Y，et al.LincROR Mediates the Suppressive Effects of Curcumin on Hepatocellular Carcinoma Through Inactivating Wnt/β-Catenin Signaling[J]．Front Pharmacol，2020，11:847.
|
| 25 |
Anwanwan D, Singh SK, Singh S, et al.Challenges in liver cancer and possible treatment approaches[J]．Biochim Biophys Acta Rev Cancer，2020，1873(1):188314.
|